There are hundreds of cell types in the human body, each with a specific role spelled out in their DNA. In theory, all it ...

The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...

The SWI/SNF Ig-Fold for Transcription Factor Interactions or 'SWIFT' domain on mSWI/SNF chromatin remodeling complexes engage ...

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

When Jorie Kraus was diagnosed with an incurable rare disease, two young researchers created an AI tool to find a treatment.

Tryptophan does far more than help us sleep—it fuels brain chemistry, energy production, and mood-regulating ...

Using CLASSIC, Rice researchers realized that circuits are variable, having multiple pathways to elicit the same outcome.

REGENXBIO Inc. (Nasdaq: RGNX) highlighted progress and upcoming anticipated milestones across its pipeline of AAV gene therapies for rare and retinal diseases. "2026 is set to be a transformative year ...

Eleven patients with refractory autoimmune hemolytic anemia (AIHA) were all brought into drug-free remission with CAR T-cell ...

Scientists are searching for therapeutics that mimic the life-extending benefits of caloric restriction, exercise, and a good ...